TrialDiabetes, obesity & metabolism2017

Rationale, design and baseline characteristics of the CANagliflozin cardioVascular Assessment Study-Renal (CANVAS-R): A randomized, placebo-controlled trial.

Bruce Neal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.